ArticleInternational journal of molecular sciences2023

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy.

Maggie Lutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.